LaunchPad Medical Executes Definitive License Agreement with Stryker for Novel Bone Adhesive Technology (press release)
LaunchPad Medical, LLC announced today that it has entered into a definitive agreement to license Stryker Corporation's (NYSE: SYK) bone adhesive technology, which is based on a unique synthetic biomaterial. Under the terms of the agreement, LaunchPad has received an exclusive worldwide license from Stryker for this technology which is covered by four issued and three pending U.S. patents and includes data from multiple pre-clinical animal studies. LaunchPad will seek to co...
Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.
Hit the SUBSCRIBE button at the top of the homepage.